Paul Rudd Drayson, Baron Drayson (born 5 March 1960)[1] is a British businessman, amateur racing driver and Labour politician. He was Minister of Science in the Department for Business, Innovation and Skills until May 2010, where he replaced Ian Pearson. In June 2009 he was additionally appointed as Minister of State for Strategic Defence Acquisition Reform at the Ministry of Defence.[2] After losing his ministerial positions in the General Election 2010 he decided to devote himself totally towards his motorsports company Drayson Racing Technology.[3] He is chairman and CEO of Drayson Technologies Ltd.[4]
Early life and career
After attending St Dunstan's College, Drayson graduated from Aston University in Production Engineering, followed in 1986 by a PhD in robotics.[5] From 1986 to 1991 he was managing director of the Lambourn Food Company. From 1992 to 1998 he was managing director of Justin de Blank Ltd.
In 1993 Drayson co-founded PowderJect Pharmaceuticals plc in Oxford which specialised in the production of vaccines, and was Chief Executive until 2003 when PowderJect was acquired by Chiron Corp.[6]
Between 2001 and 2002, Drayson was the Chairman of the BioIndustry Association. From 2002 to 2005 he was chairman of the fundraising campaign to build a children's hospital at John Radcliffe Hospital in Oxford. Since 2003, he has been the Entrepreneur-in-Residence at the Said Business School, Oxford University.
Drayson is the current president of the Motorsport Industry Association. He is chairman and CEO of Drayson Technologies Ltd near Oxford.[4]
Labour Party
Drayson has been a large contributor to the Labour Party, with BBC News reporting in 2005 that he "was made a lord and then the UK defence procurement minister after giving New Labour more than £1m."[7] He donated £100,000 in 2002 before PowderJect Pharmaceuticals plc was awarded a £32million contract for a smallpox vaccine. He donated £505,000 on 17 June 2004 six weeks after being appointed to the House of Lords by Tony Blair and a further £500,000 on 21 December 2004.[8]
Sensyne Health, floated on the AIM in 2018, uses NHS data to provide clinical insights to the pharmaceutical industry.
In 2020 Drayson was accused of creating a culture of fear at Sensyne.[13] It had data-sharing agreements with 12 NHS trusts, which were given shares in the company.[14]
In April 2022 Drayson was ousted as chief executive,[15] shortly after the company's financial report claimed that it would run out of money by February 2022.[16]
Drayson is married to Elspeth Bellhouse, the daughter of scientist Brian Bellhouse.[17] They have five children, and live between homes in London and Nether Lypiatt Manor near Stroud in Gloucestershire, purchased for £5.75 million in 2006 from Prince and Princess Michael of Kent.[18]
Drayson was born blind in one eye which, under FIA rules, prevented him from acquiring an international racing licence for participation in the Le Mans 24 Hours. In light of his performance during the 2008 ALMS season and FIA rule changes, he was granted an international licence to allow him the chance of competing in the 2009 24 Hours of Le Mans.[21] Drayson finished 37th overall and 12th in class at the race. He also competed at the 2010 event but failed to finish.
Drayson has currently competed in two seasons of the ALMS with a best finish of a win at the 2010 Road America race in a LMP Lola B09/60. For 2011, Drayson made the switch to the EV Cup, a new championship for electric cars. He will drive a Westfield iRACER.[22][needs update]
Sable a Mullet of eight points gyronny Or and Argent between four strands of DNA issuing in saltire Argent and four strands of DNA issuing in cross Or
Supporters
On either side a Jaguar Sable holding in the interior forepaw a Rapier Argent hilt pommel and guard Or
Motto
SEEK KNOWLEDGE
Badge
A Jaguar rampant Sable holding in the dexter forepaw a Rapier Argent hilt pommel and guard Or
Symbolism
The grantee's interests in fencing and motor racing are featured as is his career in the pharmaceutical industry which is reflected in the strands of DNA.